Clinical Trial Update: Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck

View source ↗

Summary

This clinical trial is evaluating tumor-informed circulating tumor DNA (ctDNA) surveillance for detecting measurable residual disease after curative-intent trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Squamous Cell Carcinoma of Head and Neck | Status: RECRUITING